Evidence map›Paper›PMID 33350167›Full record

ArticleESC heart failure2021

Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study.

Peter U Heuschmann, Felipe A Montellano, Kathrin Ungethüm, Viktoria Rücker, Silke Wiedmann, Daniel Mackenrodt, Anika Quilitzsch, Timo Ludwig, Peter Kraft, Judith Albert and 5 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Cardiac dysfunction after acute ischaemic stroke: Long-term outcomes from the SICFAIL cohort.International journal of cardiology. Heart & vasculature · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Stroke-Heart Syndrome: Recent Advances and Challenges.Journal of the American Heart Association · 2022
    Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Peter U HeuschmannInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Str. 2, Würzburg, 97080, Germany.ORCID 0000-0002-2681-3515
Felipe A MontellanoInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Str. 2, Würzburg, 97080, Germany.ORCID 0000-0002-9438-0854
Kathrin UngethümInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Str. 2, Würzburg, 97080, Germany.ORCID 0000-0001-6453-4587
Viktoria RückerInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Str. 2, Würzburg, 97080, Germany.
Silke WiedmannInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Str. 2, Würzburg, 97080, Germany.
Daniel MackenrodtInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Str. 2, Würzburg, 97080, Germany.
Anika QuilitzschInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Str. 2, Würzburg, 97080, Germany.
Timo LudwigInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Str. 2, Würzburg, 97080, Germany.
Peter KraftDepartment of Neurology, University Hospital Würzburg, Würzburg, Germany.
Judith AlbertComprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
Caroline MorbachComprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
Stefan FrantzComprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
Stefan StörkComprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
Karl Georg HaeuslerComprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
Christoph KleinschnitzDepartment of Neurology, University Hospital Essen, Essen, Germany.
University of Würzburg · DEUniversitätsklinikum Würzburg · DEEssen University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsIschaemic stroke (IS) might induce alterations of cardiac function. Prospective data on frequency of cardiac dysfunction and heart failure (HF) after IS are lacking. We assessed prevalence and determinants of diastolic dysfunction (DD), systolic dysfunction (SD), and HF in patients with acute IS. METHODS AND

resultsThe Stroke-Induced Cardiac FAILure in mice and men (SICFAIL) study is a prospective, hospital-based cohort study. Patients with IS underwent a comprehensive assessment of cardiac function in the acute phase (median 4 days after IS) including clinical examination, standardized transthoracic echocardiography by expert sonographers, and determination of blood-based biomarkers. Information on demographics, lifestyle, risk factors, symptoms suggestive of HF, and medical history was collected by a standardized personal interview. Applying current guidelines, cardiac dysfunction was classified based on echocardiographic criteria into SD (left ventricular ejection fraction < 52% in men or <54% in women) and DD (≥3 signs of DD in patients without SD). Clinically overt HF was classified into HF with reduced, mid-range, or preserved ejection fraction. Between January 2014 and February 2017, 696 IS patients were enrolled. Of them, patients with sufficient echocardiographic data on SD were included in the analyses {n = 644 patients [median age 71 years (interquartile range 60-78), 61.5% male]}. In these patients, full assessment of DD was feasible in 549 patients without SD (94%). Prevalence of cardiac dysfunction and HF was as follows: SD 9.6% [95% confidence interval (CI) 7.6-12.2%]; DD in patients without SD 23.3% (95% CI 20.0-27.0%); and clinically overt HF 5.4% (95% CI 3.9-7.5%) with subcategories of HF with preserved ejection fraction 4.35%, HF with mid-range ejection fraction 0.31%, and HF with reduced ejection fraction 0.78%. In multivariable analysis, SD and fulfilment of HF criteria were associated with history of coronary heart disease [SD: odds ratio (OR) 3.87, 95% CI 1.93-7.75, P = 0.0001; HF: OR 2.29, 95% CI 1.04-5.05, P = 0.0406] and high-sensitive troponin T at baseline (SD: OR 1.78, 95% CI 1.31-2.42, P = 0.0003; HF: OR 1.66, 95% CI 1.17-2.33, P = 0.004); DD was associated with older age (OR 1.08, 95% CI 1.05-1.11, P < 0.0001) and treated hypertension vs. no hypertension (OR 2.84, 95% CI 1.23-6.54, P = 0.0405).

conclusionsA substantial proportion of the study population exhibited subclinical and clinical cardiac dysfunction. SICFAIL provides reliable data on prevalence and determinants of SD, DD, and clinically overt HF in patients with acute IS according to current guidelines, enabling further clarification of its aetiological and prognostic role.

Indexed as

Brain IschemiaHeart FailureIschemic StrokeStrokeAgedCohort StudiesFemaleHumansMalePrevalenceProspective StudiesStroke VolumeVentricular Function, LeftCardiac dysfunction| Brain natriuretic peptideHeart failureStrokeTroponin

Identifiers

PMID33350167
PMCPMC8006617
OpenAlexW3113795984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.